P-Glycoprotein expression in human retinal pigment epithelium cell lines-Reference-Cited by-同舟云学术

P-Glycoprotein expression in human retinal pigment epithelium cell lines

Published:2006-07 Issue:1 Volume:83 Page:24-30
ISSN:0014-4835
Container-title:Experimental Eye Research
language:en
Short-container-title:Experimental Eye Research

Author:

Constable Paul A.,Lawrenson John G.,Dolman Diana E.M.,Arden Geoffrey B.,Abbott N. Joan

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Reference33 articles.

1. Transscleral drug delivery to the retina and choroid;Ambati;Prog. Retin. Eye Res.,2002

2. Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor;Aukunuru;Pharm. Res.,2001

3. Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4;Begley;J. Neurochem.,1996

4. The blood-retinal barriers system. Basic concepts and clinical evaluation;Cunha-Vaz;Exp. Eye Res.,2004

5. A human retinal pigment epithelial cell line that retains epithelial characteristics after prolonged culture;Davis;Invest. Ophthalmol. Vis. Sci.,1995

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biodegradable microspheres come into sight: A promising biomaterial for delivering drug to the posterior segment of the eyeball;Materials Today Bio;2024-08

2. In vitro and in vivo characterization of human serum albumin-based PEGylated nanoparticles for BDNF and NT3 codelivery;International Journal of Biological Macromolecules;2024-04

3. Carrier-Mediated Delivery of Low-Molecular-Weight N-Containing Drugs across the Blood–Brain Barrier or the Blood–Retinal Barrier Using the Proton-Coupled Organic Cation Antiporter;Future Pharmacology;2023-10-12

4. In vitro laboratory models of proliferative vitreoretinopathy;Survey of Ophthalmology;2023-09

5. Recent advances and prospects for lipid-based nanoparticles as drug carriers in the treatment of human retinal diseases;Advanced Drug Delivery Reviews;2023-08